These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 24665135)

  • 1. A Caenorhabditis elegans-based assay recognizes immunoglobulin light chains causing heart amyloidosis.
    Diomede L; Rognoni P; Lavatelli F; Romeo M; del Favero E; Cantù L; Ghibaudi E; di Fonzo A; Corbelli A; Fiordaliso F; Palladini G; Valentini V; Perfetti V; Salmona M; Merlini G
    Blood; 2014 Jun; 123(23):3543-52. PubMed ID: 24665135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential recruitment efficacy of patient-derived amyloidogenic and myeloma light chain proteins by synthetic fibrils-A metric for predicting amyloid propensity.
    Martin EB; Williams A; Wooliver C; Heidel RE; Adams S; Dunlap J; Ramirez-Alvarado M; Blancas-Mejia LM; Lands RH; Kennel SJ; Wall JS
    PLoS One; 2017; 12(3):e0174152. PubMed ID: 28350808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating heart-specific toxicity of amyloidogenic immunoglobulin light chains: A lesson from C. elegans.
    Diomede L; Rognoni P; Lavatelli F; Romeo M; di Fonzo A; Foray C; Fiordaliso F; Palladini G; Valentini V; Perfetti V; Salmona M; Merlini G
    Worm; 2014; 3(3):e965590. PubMed ID: 26430549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel mitochondrial protein interactors of immunoglobulin light chains causing heart amyloidosis.
    Lavatelli F; Imperlini E; Orrù S; Rognoni P; Sarnataro D; Palladini G; Malpasso G; Soriano ME; Di Fonzo A; Valentini V; Gnecchi M; Perlini S; Salvatore F; Merlini G
    FASEB J; 2015 Nov; 29(11):4614-28. PubMed ID: 26220173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Worming along in amyloid cardiotoxicity.
    Liao R
    Blood; 2014 Jun; 123(23):3525-6. PubMed ID: 24904094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac Light Chain Amyloidosis: The Role of Metal Ions in Oxidative Stress and Mitochondrial Damage.
    Diomede L; Romeo M; Rognoni P; Beeg M; Foray C; Ghibaudi E; Palladini G; Cherny RA; Verga L; Capello GL; Perfetti V; Fiordaliso F; Merlini G; Salmona M
    Antioxid Redox Signal; 2017 Sep; 27(9):567-582. PubMed ID: 28132512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanobodies counteract the toxicity of an amyloidogenic light chain by stabilizing a partially open dimeric conformation.
    Broggini L; Barzago MM; Speranzini V; Schulte T; Sonzini F; Giono M; Romeo M; Milani P; Caminito S; Mazzini G; Rognoni P; Merlini G; Pappone C; Anastasia L; Nuvolone M; Palladini G; Diomede L; Ricagno S
    J Mol Biol; 2023 Dec; 435(24):168320. PubMed ID: 37865287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cu(II) Binding Increases the Soluble Toxicity of Amyloidogenic Light Chains.
    Russo R; Romeo M; Schulte T; Maritan M; Oberti L; Barzago MM; Barbiroli A; Pappone C; Anastasia L; Palladini G; Diomede L; Ricagno S
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary (AL) amyloidosis in plasma cell disorders.
    Müller AM; Geibel A; Neumann HP; Kühnemund A; Schmitt-Gräff A; Böhm J; Engelhardt M
    Oncologist; 2006; 11(7):824-30. PubMed ID: 16880241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in specific structural regions of immunoglobulin light chains are associated with free light chain levels in patients with AL amyloidosis.
    Poshusta TL; Sikkink LA; Leung N; Clark RJ; Dispenzieri A; Ramirez-Alvarado M
    PLoS One; 2009; 4(4):e5169. PubMed ID: 19365555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin light chain amyloidosis and the kidney.
    Gertz MA; Lacy MQ; Dispenzieri A
    Kidney Int; 2002 Jan; 61(1):1-9. PubMed ID: 11786079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An N-glycosylation hotspot in immunoglobulin κ light chains is associated with AL amyloidosis.
    Nevone A; Girelli M; Mangiacavalli S; Paiva B; Milani P; Cascino P; Piscitelli M; Speranzini V; Cartia CS; Benvenuti P; Goicoechea I; Fazio F; Basset M; Foli A; Nanci M; Mazzini G; Caminito S; Sesta MA; Casarini S; Rognoni P; Lavatelli F; Petrucci MT; Olimpieri PP; Ricagno S; Arcaini L; Merlini G; Palladini G; Nuvolone M
    Leukemia; 2022 Aug; 36(8):2076-2085. PubMed ID: 35610346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent structural and biophysical traits link with immunoglobulin light chains amyloid propensity.
    Oberti L; Rognoni P; Barbiroli A; Lavatelli F; Russo R; Maritan M; Palladini G; Bolognesi M; Merlini G; Ricagno S
    Sci Rep; 2017 Dec; 7(1):16809. PubMed ID: 29196671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteotoxicity in cardiac amyloidosis: amyloidogenic light chains affect the levels of intracellular proteins in human heart cells.
    Imperlini E; Gnecchi M; Rognoni P; Sabidò E; Ciuffreda MC; Palladini G; Espadas G; Mancuso FM; Bozzola M; Malpasso G; Valentini V; Palladini G; Orrù S; Ferraro G; Milani P; Perlini S; Salvatore F; Merlini G; Lavatelli F
    Sci Rep; 2017 Nov; 7(1):15661. PubMed ID: 29142197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical study of immunoglobulin light chain amyloidosis with antibodies to the immunoglobulin light chain variable region.
    Hoshii Y; Kiyama M; Cui D; Kawano H; Ishihara T
    Pathol Int; 2006 Jun; 56(6):324-30. PubMed ID: 16704496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AL (Light-Chain) Cardiac Amyloidosis: A Review of Diagnosis and Therapy.
    Falk RH; Alexander KM; Liao R; Dorbala S
    J Am Coll Cardiol; 2016 Sep; 68(12):1323-41. PubMed ID: 27634125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tropism of organ involvement in primary systemic amyloidosis: contributions of Ig V(L) germ line gene use and clonal plasma cell burden.
    Comenzo RL; Zhang Y; Martinez C; Osman K; Herrera GA
    Blood; 2001 Aug; 98(3):714-20. PubMed ID: 11468171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human amyloidogenic light chain proteins result in cardiac dysfunction, cell death, and early mortality in zebrafish.
    Mishra S; Guan J; Plovie E; Seldin DC; Connors LH; Merlini G; Falk RH; MacRae CA; Liao R
    Am J Physiol Heart Circ Physiol; 2013 Jul; 305(1):H95-103. PubMed ID: 23624626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of light chain (AL) amyloidosis associated with IgD multiple myeloma (MM): clinical features, laboratory findings and outcome.
    Rizzi R; Miccolis R; Rinaldi E; Bonerba B; Rossini M; Manno C; Curci P; Specchia G; Liso V
    Amyloid; 2011 Jun; 18 Suppl 1():117-8. PubMed ID: 21838455
    [No Abstract]   [Full Text] [Related]  

  • 20. Recent advances in the management of AL Amyloidosis.
    Kastritis E; Dimopoulos MA
    Br J Haematol; 2016 Jan; 172(2):170-86. PubMed ID: 26491974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.